This review continues a general presentation of the principles of stereochemistry with special reference to the medicinal sciences. Here, we discuss and illustrate molecular and clinical phenomena of stereoselectivity in pharmacological effects, namely activity differences between stereoisomers, principally enantiomers. The review begins with didactic models of chiral recognition, with a main focus on the early model of Easson and Stedman. There follows a Molecular Modeling (MM) and Molecular Dynamics (MD) depiction of the differential interaction of the enantiomers of hyoscyamine with cholinergic muscarinic receptors. The next section is devoted to various rationalizations in stereoselective pharmacological activity, e.g., the influence of optical purity on enantioselectivity, Pfeiffer's rule, and eudismic analysis. The review ends with selected examples taken from various fields of preclinical and clinical pharmacology, of differences between stereoisomers in terms of drug absorption, distribution, and excretion. The influence of conformational factor in molecular pharmacology will be discussed in Part 6, while stereoselective aspects of xenobiotic metabolism will be reviewed in Parts 7 and 8.

Organic stereochemistry. Part 5 : Stereoselectivity in molecular and clinical pharmacology / B. Testa, G. Vistoli, A. Pedretti, J. Caldwell. - In: HELVETICA CHIMICA ACTA. - ISSN 0018-019X. - 96:5(2013), pp. 747-798. [10.1002/hlca.201200473]

Organic stereochemistry. Part 5 : Stereoselectivity in molecular and clinical pharmacology

G. Vistoli
Secondo
;
A. Pedretti
Penultimo
;
2013

Abstract

This review continues a general presentation of the principles of stereochemistry with special reference to the medicinal sciences. Here, we discuss and illustrate molecular and clinical phenomena of stereoselectivity in pharmacological effects, namely activity differences between stereoisomers, principally enantiomers. The review begins with didactic models of chiral recognition, with a main focus on the early model of Easson and Stedman. There follows a Molecular Modeling (MM) and Molecular Dynamics (MD) depiction of the differential interaction of the enantiomers of hyoscyamine with cholinergic muscarinic receptors. The next section is devoted to various rationalizations in stereoselective pharmacological activity, e.g., the influence of optical purity on enantioselectivity, Pfeiffer's rule, and eudismic analysis. The review ends with selected examples taken from various fields of preclinical and clinical pharmacology, of differences between stereoisomers in terms of drug absorption, distribution, and excretion. The influence of conformational factor in molecular pharmacology will be discussed in Part 6, while stereoselective aspects of xenobiotic metabolism will be reviewed in Parts 7 and 8.
English
molecular pharmacology; stereochemistry; stereoselectivity; symmetry elements
Settore CHIM/08 - Chimica Farmaceutica
Review essay
Esperti anonimi
Ricerca applicata
Pubblicazione scientifica
2013
Wiley
96
5
747
798
52
Pubblicato
Periodico con rilevanza internazionale
CrossRef
NON aderisco
info:eu-repo/semantics/article
Organic stereochemistry. Part 5 : Stereoselectivity in molecular and clinical pharmacology / B. Testa, G. Vistoli, A. Pedretti, J. Caldwell. - In: HELVETICA CHIMICA ACTA. - ISSN 0018-019X. - 96:5(2013), pp. 747-798. [10.1002/hlca.201200473]
reserved
Prodotti della ricerca::01 - Articolo su periodico
4
262
Article (author)
no
B. Testa, G. Vistoli, A. Pedretti, J. Caldwell
File in questo prodotto:
File Dimensione Formato  
05-Helv.Chim.Acta_96-5_2013.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.76 MB
Formato Adobe PDF
1.76 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/222504
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact